Search

everythinglearnresearchcommunity

for

Search:↓

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

DKK-1 gene linked to hair loss in AGA and AA patients; more research needed for potential therapy.

The conclusion is that Erosive Pustular Dermatosis of the Scalp is a rare condition best treated with strong topical steroids and sometimes systemic treatment.

A 3-year-old girl with skin mast cell buildup and congenital baldness improved with treatment, suggesting a rare link between these conditions.

The research found that a specific gene mutation causes fewer hair follicles and disrupted hair growth cycles, leading to thin and short hair in people with Hypotrichosis with Juvenile Macular Dystrophy.

A man with a birthmark on his scalp developed hair loss that improved with treatment, but the link between the birthmark and hair loss was unclear.

Women with diffuse hair loss often have lower iron and vitamin D levels, but their thyroid function is typically normal.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.

Alopecia areata can look like frontal fibrosing alopecia, making diagnosis hard.

Biopsy can differentiate between alopecia areata and androgenic alopecia, and if more information is needed, testing for CD3 and CD8 can help.

Trichoscopy is a useful method for identifying primary cicatricial alopecias and their specific types.

Erosive pustular dermatosis of the scalp is a type of skin inflammation often confused with other conditions, requiring continuous treatment.

Increased mucin in the skin might indicate lupus in patients with hair loss, but more research is needed.

Brodalumab effectively treated a man's severe hand and foot psoriasis.

The conclusion is that differentiating wound types in RDEB patients is important for clinical trials and understanding the disease.

Skin disease activity scores can help decide when skin symptoms no longer affect the quality of life in patients with mild dermatomyositis.

Psoriasis patients are willing to pay less than the cost of biologic treatments for remission and don't expect complete or long-term symptom clearance.

The patient's hair loss is most likely due to diffuse alopecia areata.

Platelet Rich Plasma can potentially help in restoring hair loss, but more research with larger groups is needed to confirm its effectiveness and standardize its use.

Bimatoprost is safe but not effective for severe eyelash loss from alopecia areata, possibly helping those with less loss.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Lupus can cause hair loss and nail changes, with treatments available for both.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

Secukinumab can cause hair loss, which may improve after stopping the medication.

A protein combining parathyroid hormone and collagen helped hair regrow in mice with a hair loss condition.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

To manage diffuse hair loss, identify the cause, improve nutrition, remove triggers, and use specific treatments like minoxidil or finasteride.